Table 3 Comparison of findings from mucosal cutting biopsy specimens and surgically resected specimens
Group I | Case | CD34 | c-kit | α-SMA | Desmin | s-100 | Ki-67 | Nuclear fission | |
|---|---|---|---|---|---|---|---|---|---|
1 | Biopsy | + | + | − | − | − | 1% | − | |
Resected specimen | + | + | − | − | − | 1% | − | ||
2 | Biopsy | + | + | − | − | − | <10% | − | |
Resected specimen | + | + | − | − | − | 1% | 2 | ||
3 | Biopsy | + | + | − | − | − | 1% | − | |
Resected specimen | + | + | − | − | − | 1% | <5 | ||
4 | Biopsy | + | + | − | − | − | 1% | − | |
Resected specimen | + | + | − | − | − | <1% | − | ||
5 | Biopsy | + | + | − | − | − | 2% | − | |
Resected specimen | + | + | − | − | − | 1% | − | ||
6 | Biopsy | + | + | − | − | − | 3% | − | |
Resected specimen | + | + | − | − | − | 3% | − | ||
7 | Biopsy | + | + | − | − | − | <10% | <5 | |
Resected specimen | + | + | − | − | − | <10% | <5 | ||
8 | Biopsy | + | + | − | − | − | <10% | − | |
Resected specimen | + | + | − | − | − | 5% | − | ||
9 | Biopsy | + | + | − | − | − | <10% | <5 | |
Resected specimen | + | + | − | − | − | <10% | <5 | ||
10 | Biopsy | + | + | − | − | − | <10% | − | |
Resected specimen | + | + | − | − | − | <10% | − | ||
Group II | Case | CD34 | c-kit | α-SMA | Desmin | s-100 | Ki-67 | nuclear fission | |
1 | Biopsy | + | + | − | − | − | <10% | − | |
Resected specimen | + | + | − | − | − | <3% | <3 | ||
2 | Biopsy | + | + | − | − | − | <10% | <5 | |
Resected specimen | + | + | − | − | − | 3% | 4 | ||
3 | Biopsy | + | + | − | − | − | 3% | − | |
Resected specimen | + | + | − | − | − | 3% | 8 | ||
4 | Biopsy | + | + | − | − | − | <1% | − | |
Resected specimen | + | + | − | − | − | <5% | − | ||
5 | Biopsy | + | + | − | − | − | 3% | − | |
Resected specimen | + | + | − | − | − | 3% | − | ||
6 | Biopsy | + | + | − | − | − | <10% | − | |
α-SMA: | Resected specimen | + | + | − | − | − | <5% | <3 | |
α-smooth muscle actin | 7 | Biopsy | + | + | − | − | − | <10% | − |
Resected specimen | + | + | − | − | − | 3% | − |